Pages that link to "Q44471704"
Jump to navigation
Jump to search
The following pages link to Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study (Q44471704):
Displaying 50 items.
- Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy (Q24606246) (← links)
- Critical evaluation of urinary markers for bladder cancer detection and monitoring (Q24654929) (← links)
- Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder (Q26775775) (← links)
- Image-guided cancer surgery using near-infrared fluorescence (Q30432014) (← links)
- Mapping of oxidative stress responses of human tumor cells following photodynamic therapy using hexaminolevulinate (Q33293875) (← links)
- Confocal laser endomicroscopy for the diagnosis of urothelial bladder neoplasia: a technology of the future? (Q33657242) (← links)
- New optical imaging technologies for bladder cancer: considerations and perspectives (Q33670217) (← links)
- Beyond the photodynamic diagnosis: Searching for excellence in the diagnosis of non-muscle-invasive bladder cancer (Q33676296) (← links)
- Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles (Q33687975) (← links)
- Imaging and photodynamic therapy: mechanisms, monitoring, and optimization (Q33960755) (← links)
- Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients (Q34372378) (← links)
- HAL fluorescence cystoscopy and TURB one year of Romanian experience (Q34480868) (← links)
- Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer (Q35082831) (← links)
- Fluorescent diagnosis of urinary bladder cancer-a comparison of two diagnostic modalities. (Q35210413) (← links)
- Best practice in the treatment of nonmuscle invasive bladder cancer (Q35688392) (← links)
- Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist! (Q36065525) (← links)
- DNA-based molecular cytology for bladder cancer surveillance (Q36418392) (← links)
- 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives (Q36423131) (← links)
- Hexyl aminolevulinate: in the detection of bladder cancer (Q36441471) (← links)
- Efficacy and safety of hexaminolevulinate fluorescence cystoscopy in the diagnosis of bladder cancer (Q36492456) (← links)
- Fluorescence diagnosis of bladder cancer (Q36533801) (← links)
- Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion (Q36850460) (← links)
- The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer (Q36964427) (← links)
- Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention. (Q36994181) (← links)
- Photodynamic diagnostics of bladder tumors (Q37141456) (← links)
- Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer. (Q37577908) (← links)
- On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds (Q37836419) (← links)
- The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard. (Q37903407) (← links)
- The Enlightenment of Bladder Cancer Treatment: Origin and Progress of Photodynamic Diagnosis (Q37932541) (← links)
- Recent advances in urinary bladder cancer detection (Q38030593) (← links)
- High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment (Q38052445) (← links)
- Follow-up procedures for non-muscle-invasive bladder cancer: an update (Q38055500) (← links)
- Contemporary diagnosis of bladder cancer (Q38089768) (← links)
- Is photodynamic diagnosis ready for introduction in urological clinical practice? (Q38114946) (← links)
- Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer (Q38156190) (← links)
- Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer (Q38163897) (← links)
- Photosensitizers in clinical PDT. (Q38232376) (← links)
- Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and futur (Q38342245) (← links)
- Photodynamic treatment with hexyl-aminolevulinate mediates reversible thiol oxidation in core oxidative stress signaling proteins (Q38805845) (← links)
- Improved Photodynamic Therapy Efficacy of Protoporphyrin IX-Loaded Polymeric Micelles Using Erlotinib Pretreatment. (Q38823173) (← links)
- Use of fluorescein isothiocyanate-human serum albumin for the intravesical photodiagnosis of non-muscle-invasive bladder cancer: an in vitro study using multicellular spheroids composed of normal human urothelial and urothelial cell carcinoma cell l (Q39620375) (← links)
- The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New Analysis (Q39634006) (← links)
- Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects (Q40109451) (← links)
- Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples (Q40151713) (← links)
- Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden (Q40609183) (← links)
- Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in T a/T1 patients: a randomized two-centre study (Q42694650) (← links)
- HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study (Q42971654) (← links)
- Hexaminolevulinate fluorescence cystoscopy in 2009 (Q43056785) (← links)
- Photodynamic diagnosis (PDD) in non-muscle invasive bladder cancer. Literature review (Q43238634) (← links)
- Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors (Q43263959) (← links)